Nature Biotechnology 2017-07-12

CRISPR–Cas9 claim sets and the potential to stifle innovation

Benjamin N Gray, W Murray Spruill

Index: 10.1038/nbt.3913

Full Text: HTML

Abstract

Extremely broad claims surrounding Cas9 nucleases have the potential to stifle innovation in the field of genome editing.